A M Hanby

Author PubWeight™ 77.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997 2.76
2 Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol 2004 2.36
3 The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991 2.32
4 Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995 2.02
5 High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A 1997 1.81
6 Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993 1.78
7 Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics 1995 1.59
8 The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol 1993 1.56
9 Multiple tissue core arrays in histopathology research: a validation study. J Pathol 2000 1.51
10 Mammary hamartoma--a review of 35 cases. Histopathology 1992 1.50
11 hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A 1993 1.48
12 Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 1992 1.41
13 Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol 2008 1.35
14 The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut 1996 1.35
15 Molecular characteristics of serrated adenomas of the colorectum. Gut 2002 1.31
16 X-ray scatter signatures for normal and neoplastic breast tissues. Phys Med Biol 1999 1.30
17 Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A 1996 1.29
18 Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 1995 1.26
19 Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 2009 1.24
20 HER2 testing in the UK: further update to recommendations. J Clin Pathol 2008 1.22
21 Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol 1997 1.22
22 Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol 2001 1.16
23 A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol 2008 1.15
24 Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 2001 1.12
25 Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours. J Pathol 1991 1.09
26 Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol 2000 1.09
27 Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res 1996 1.07
28 Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 1993 1.07
29 HER2 testing in the UK: consensus from a national consultation. J Clin Pathol 2007 1.06
30 Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Am J Pathol 1996 1.02
31 The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochem J 1994 1.01
32 Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth Differ 1994 1.00
33 Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer. Br J Surg 2014 0.97
34 The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J Pathol 2001 0.97
35 Expression and purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to search for trefoil-binding sites. Eur J Biochem 1993 0.96
36 Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. J Clin Pathol 2004 0.95
37 Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. Biochem J 1992 0.95
38 Influence of inflammation and atrophy on pancreatic secretory trypsin inhibitor levels within the gastric mucosa. Gastroenterology 1994 0.94
39 mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol 2008 0.92
40 Testing for HER2 in breast cancer. Histopathology 2004 0.92
41 Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon. Am J Pathol 1995 0.91
42 BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data. J Pathol 2002 0.91
43 Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation. Biochim Biophys Acta 1996 0.90
44 Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay. J Mol Diagn 2000 0.90
45 Correlation of energy dispersive diffraction signatures and microCT of small breast tissue samples with pathological analysis. Phys Med Biol 2007 0.89
46 Oestrogen and progesterone receptors in breast cancer: past, present and future. Histopathology 2001 0.89
47 Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast. Int J Cancer 2000 0.89
48 Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator. J Pathol 2008 0.88
49 The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J Pathol 1999 0.86
50 H-RYK, an unusual receptor kinase: isolation and analysis of expression in ovarian cancer. Mol Med 1996 0.86
51 Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas. Am J Pathol 1996 0.85
52 Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci 1994 0.84
53 The kinetic organization of the ulcer-associated cell lineage (UACL): delineation of a novel putative stem-cell region. Epithelial Cell Biol 1994 0.83
54 Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS). Eur J Surg Oncol 2013 0.83
55 Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer. J Pathol 1998 0.82
56 Fine-needle interstitial photodynamic therapy of the lung parenchyma: photosensitizer distribution and morphologic effects of treatment. Chest 1999 0.81
57 Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut 1995 0.81
58 Epstein-Barr virus-related oral T-cell lymphoma associated with human immunodeficiency virus immunosuppression. Blood 1993 0.80
59 Identification by differential display of a protein phosphatase-2A regulatory subunit preferentially expressed in malignant melanoma cells. Int J Cancer 1999 0.80
60 The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur J Cancer 2000 0.78
61 Intramuscular hemangioma of the sternomastoid muscle. Head Neck 1990 0.78
62 Mitotic counts provide additional prognostic information in grade II mammary carcinoma. J Pathol 2002 0.78
63 Lymphangiogenesis in abdominal aortic aneurysm. Br J Surg 2013 0.78
64 Angiogenesis in breast cancer: how should we measure this? (Review). Oncol Rep 2005 0.78
65 Tissue microarrays--big potential from small samples (review). Int J Oncol 2004 0.77
66 Cutaneous squamoproliferative lesions in renal transplant recipients. Differentiation from lesions in immunocompetent patients. Am J Dermatopathol 1995 0.77
67 Radiation and other pathological changes in breast tissue after conservation treatment for carcinoma. J Clin Pathol 1990 0.75
68 Adverse effects of dyes used in sentinel node biopsy on immunocytochemical determination of hormone receptors in breast cancer cells. J Clin Pathol 2007 0.75
69 An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model. Br J Cancer 1996 0.75
70 Angiosarcoma of the skin overlying an irradiated breast. Breast Cancer Res Treat 1991 0.75
71 An alternative method of dissecting mastectomy specimens. Histopathology 2006 0.75
72 Susceptibility of the rabbit and the rat to steroid osteonecrosis--an experimental study. Transplantation 1987 0.75
73 Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma. J Pathol 1995 0.75
74 The assessment of proliferating cell nuclear antigen (PCNA)immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 2002 0.75